2C-T-7

[1] – Eshleman, A. J., et al. (2014). "Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function." Psychopharmacology (Berl) 231(5): 875-888.

 

[2] – The Vaults of Erowid, erowid.org, 10 de Fevereiro de 2015, consultado a  em https://www.erowid.org/chemicals/mdma/mdma_info7.shtml

 

[3] - King, L. A. (2014). "New phenethylamines in Europe." Drug Test Anal 6(7-8): 808-818.

 

 

[4] - European Monitoring Center for Drugs and Drug Addiction, emcdda.europa.eu, 11 de Maio de 2015, consultado em http://www.emcdda.europa.eu/index.cfm

 

 

[5] - Fantegrossi, W. E., et al. (2005). "Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats." Psychopharmacology (Berl) 181(3): 496-503.

 

 

[6] - Theobald, D. S. and H. H. Maurer (2007). "Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series)." Biochemical Pharmacology 73(2): 287-297.

 

 

[7] Peters, F. T. and M. R. Meyer (2011). "In vitro approaches to studying the metabolism of new psychoactive compounds." Drug Test Anal 3(7-8): 483-495

 

 

[8] Rickli, A., et al. (2015). "Pharmacological profile of novel psychoactive benzofurans." Br J Pharmacol.

 

 

 

[9] – Toxicology Data Network, toxnet.nlm.nih.gov, 2 d eDezembro de 2014, disponível em http://toxnet.nlm.nih.gov/cgi-

bin/sis/search2/f?./temp/~56FT6f:2

 

 

[10] – Drugs-forum, drugs-forum.com, 2014, disponível em https://drugs-forum.com/forum/showwiki.php?title=2C-T-7